製品の概要

  • 製品名Bradykinin
  • 製品の詳細
    Bradykinin receptor agonist
  • 生理活性の詳細Endogenous bradykinin receptor peptide agonist. Displays selectivity at bradykinin B2 receptor over B1. Formed following pathophysiological stimuli such as inflammation, tissue damage or anoxia. Implicated in pain conditions associated with trauma and inflammation.
  • 精製度> 98%

製品の特性

    Bradykinin (ab120470) 使用論文

    This product has been referenced in:
    • López-Valdés HE  et al. Bradykinin increases resensitization of purinergic receptor signaling in glioma cells. Cancer Cell Int 10:35 (2010). Read more (PubMed: 20875097) »
    • Burgess GM  et al. Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia. Br J Pharmacol 129:77-86 (2000). Read more (PubMed: 10694205) »
    • Regoli D  et al. Bradykinin receptors and their antagonists. Eur J Pharmacol 348:1-10 (1998). Read more (PubMed: 9650825) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120470.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"